Literature DB >> 17689734

Impaired isotonic contractility and structural abnormalities in the diaphragm of congestive heart failure rats.

Hieronymus W H van Hees1, Henricus F M van der Heijden, Theo Hafmans, Leo Ennen, Leo M A Heunks, Freek W A Verheugt, P N Richard Dekhuijzen.   

Abstract

BACKGROUND: Metabolic alterations and decreased isometric force generation have been demonstrated in different animal models for congestive heart failure (CHF). However, as few morphological examinations have been performed on the CHF diaphragm, it is unknown if structural abnormalities comprise a substrate for diaphragm dysfunction in CHF. Therefore, we investigated CHF diaphragm isometric and isotonic contractility together with the presence of structural abnormalities.
METHODS: Isometric twitch (P(t)) and maximal (P(o)) force, shortening velocity and power generation were determined in diaphragm bundles from rats with CHF, induced by myocardial infarction, and sham-operated rats. Immunofluorescence staining of myosin and sarcolemmal components fibronectin, laminin and dystrophin was performed on diaphragm cryosections. Electron microscopy was used to study the ultrastructure of diaphragm fibres.
RESULTS: P(t) and P(o) were respectively approximately 30% and approximately 20% lower in CHF diaphragm bundles than sham. Maximal shortening velocity was reduced by approximately 20% and maximal power generation by approximately 35%. Structural abnormalities were frequently observed in CHF diaphragm fibres and were mainly marked by focal degradation of sarcomeric constituents and expansion of intermyofibrillar spaces with swollen and degenerated mitochondria. Immunofluorescence microscopy showed reduced staining intensities of myosin in CHF diaphragm fibres compared to sham. No differences were found regarding the distribution of fibronectin, laminin and dystrophin, indicating an intact sarcolemma in both groups.
CONCLUSION: This study demonstrates impaired isometric and isotonic contractility together with structural abnormalities in the CHF diaphragm. The sarcolemma of CHF diaphragm fibres appeared to be intact, excluding a role for sarcolemmal injuries in the development of CHF diaphragm dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17689734     DOI: 10.1016/j.ijcard.2007.06.080

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Authors:  Marios Panagiotou; Andrew J Peacock; Martin K Johnson
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Diaphragm muscle weakness in mice is early-onset post-myocardial infarction and associated with elevated protein oxidation.

Authors:  T Scott Bowen; Norman Mangner; Sarah Werner; Stefanie Glaser; Yvonne Kullnick; Andrea Schrepper; Torsten Doenst; Andreas Oberbach; Axel Linke; Leif Steil; Gerhard Schuler; Volker Adams
Journal:  J Appl Physiol (1985)       Date:  2014-10-30

3.  NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.

Authors:  Bumsoo Ahn; Adam W Beharry; Gregory S Frye; Andrew R Judge; Leonardo F Ferreira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-24       Impact factor: 5.464

Review 4.  Respiratory muscle function and exercise intolerance in heart failure.

Authors:  Jorge P Ribeiro; Gaspar R Chiappa; J Alberto Neder; Lutz Frankenstein
Journal:  Curr Heart Fail Rep       Date:  2009-06

5.  Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content.

Authors:  Hyacinth M Empinado; Gergana M Deevska; Mariana Nikolova-Karakashian; Jeung-Ki Yoo; Demetra D Christou; Leonardo F Ferreira
Journal:  Eur J Heart Fail       Date:  2014-03-04       Impact factor: 15.534

Review 6.  Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology.

Authors:  Rachel C Kelley; Leonardo F Ferreira
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

7.  Pharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure.

Authors:  Orlando Laitano; Bumsoo Ahn; Nikhil Patel; Philip D Coblentz; Ashley J Smuder; Jeung-Ki Yoo; Demetra D Christou; Peter J Adhihetty; Leonardo F Ferreira
Journal:  J Appl Physiol (1985)       Date:  2016-02-04

8.  Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure.

Authors:  Dirk Habedank; F Joachim Meyer; Roland Hetzer; Stefan D Anker; Ralf Ewert
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-06-21       Impact factor: 12.910

9.  Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation.

Authors:  Bumsoo Ahn; Philip D Coblentz; Adam W Beharry; Nikhil Patel; Andrew R Judge; Jennifer S Moylan; Charles W Hoopes; Mark R Bonnell; Leonardo F Ferreira
Journal:  Front Physiol       Date:  2017-01-09       Impact factor: 4.566

10.  Diaphragm atrophy and contractile dysfunction in a murine model of pulmonary hypertension.

Authors:  Bumsoo Ahn; Hyacinth M Empinado; Monsour Al-Rajhi; Andrew R Judge; Leonardo F Ferreira
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.